Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
Scientists build first fully human bone marrow model to revolutionize blood d...
BY THE OPTIMIST DAILY EDITORIAL TEAM In a transformative leap for regenerative medicine, scientists have developed the first entirely human-engineered bone marrow system. This ...
Read More7 cold and flu season mistakes doctors want you to quit making
BY THE OPTIMIST DAILY EDITORIAL TEAM You’ve heard the warnings: cold and flu season is no joke. But despite our best intentions (and fully ...
Read MoreThree ways we can repurpose closed department stores
40 percent of US department stores have closed their doors in the past five years, but the question remains: what do we do with ...
Read MoreHubble takes beautiful image of galaxies “dancing”
The Hubble Space Telescope ventured into space over three decades ago in 1990, and has observed around 50,000 celestial bodies to date. During this ...
Read More
